Company News

  • 8 February 2019

    Cognoa devices for autism obtain FDA breakthrough status

    Cognoa, a digital devices maker, has obtained the US Food and Drug Administration (FDA) breakthrough device designation for its diagnostic and therapeutic devices intended for autism spectrum disorder (ASD).

Go Top